Indoco’s PAT jumps 62 per cent in Q4FY22

During the fourth quarter of FY 2021-22, revenues of Indoco Remedies grew by 35.8 per cent at Rs 400.3 crores, as against Rs 294.8 crores, same quarter last year. EBIDTA to net sales for the quarter is 20.1 per cent at Rs 80.5 crores, compared to 18.5 per cent at Rs 54.6 crores, same quarter last year. For the quarter, the Profit After Tax (PAT) to net sales is 10.1 per cent at Rs 40.4 crores, compared to 8.4 per cent at Rs 24.9 crores, same quarter last year, the company said in a statement.

For the year ending March 22, the revenues grew by 23.4 per cent at Rs 1502.7 crores, as against Rs 1217.4 crores, same period last year. EBIDTA to net sales for the period is 21.8 per cent at Rs 327 crores, compared to 18.4 per cent at Rs 223.6 crores, same period last year. For the period, the PAT to net sales is 10.3 per cent at Rs 154.5 crores, compared to 7.6 per cent at Rs 92.4 crores, same period last year, the statement added.